The perspective of the oncologist

Date 08 October 2016
Event ESMO 2016 Congress
Session Definition and management of oligoprogression during treatment with TKI inhibitors
Topics Non-Small-Cell Lung Cancer, Metastatic
Presenter Egbert Smit
Authors E.F. Smit
  • Thoracic Oncology, Het Nederlands Kanker Instituut Antoni van Leeuwenhoek (NKI-AVL), 1006 BE - Amsterdam/NL